NEW YORK (GenomeWeb) – PerkinElmer announced today that it has reorganized its corporate structure in order to better position itself to grow in certain markets and better serve customers.

The company's diagnostics business will now be a standalone business segment, focused on reproductive health, diagnostics for emerging markets, and applied genomics, and will serve clinically oriented customers in regulated markets, PerkinElmer said. It will be led by Prahlad Singh, senior vice president and president of diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.